|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||14.39 - 14.55|
|52 Week Range||11.65 - 21.59|
|Beta (5Y Monthly)||1.36|
|PE Ratio (TTM)||7.84|
|Forward Dividend & Yield||0.76 (5.36%)|
|Ex-Dividend Date||Apr 29, 2020|
|1y Target Est||14.50|
With immobile stock prices and a hangover of legal issues, these CEOs might be glad Wall Street doesn't operate like a democracy.
The best biotech companies to invest in tend to have a commonality: a strong streak of earnings growth.
The mediator Kenneth Feinberg spoke at a Zoom hearing in San Francisco federal court, where a judge still oversees nearly 2,000 unresolved cases over glyphosate-based Roundup, which Bayer acquired with its purchase of Monsanto. "We're not there yet but we are certainly making substantial progress," said Feinberg, who oversaw compensation programs for victims of the Sept. 11 attacks and 2010 Gulf of Mexico oil spill.